STARLIGHT CARDIOVASCULAR
Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease. The tools utilized to treat these youngsters were built for adult ailments and anatomy, limiting their utility for pediatric patients. Their objectives are to improve morbidity, mortality, and access to care.
STARLIGHT CARDIOVASCULAR
Social Links:
Industry:
Children Health Care Medical Device
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.starlightcardio.com
Total Employee:
11+
Status:
Active
Total Funding:
13.64 M USD
Technology used in webpage:
Euro Pound Sterling Squarespace Hosted
Similar Organizations
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
OYS Mobility
OYS Mobility develops prosthetic technology that allows people with limb loss or deformity to access healthcare and assistive devices.
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Current Employees Featured
Founder
Investors List
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute investment in Grant - Starlight Cardiovascular
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute investment in Grant - Starlight Cardiovascular
THE CATALYTIC IMPACT FOUNDATION (CIF)
THE CATALYTIC IMPACT FOUNDATION (CIF) investment in Series A - Starlight Cardiovascular
Bird B.
Bird B. investment in Series A - Starlight Cardiovascular
Consortium For Technology & Innovation in Pediatrics
Consortium For Technology & Innovation in Pediatrics investment in Grant - Starlight Cardiovascular
Official Site Inspections
http://www.starlightcardio.com Semrush global rank: 11.28 M Semrush visits lastest month: 169
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Starlight Cardiovascular"
About - Starlight Cardiovascular
Starlight Cardiovascular is developing much needed tools and devices to treat pediatric congenital heart defects (CHDs). Approximately 1.3 million babies are born each year with a CHD.See details»
Team — Starlight Cardiovascular
Alf Grunwald has served as a member of our board of directors since February 2017. Since October 2015, he has served as the Chief Executive Officer of Black Forest One GmbH & Co …See details»
Starlight Cardiovascular - Crunchbase Company Profile & Funding
Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease.See details»
Starlight Cardiovascular - LinkedIn
Starlight Cardiovascular has been awarded a $2M Phase II SBIR grant from the National Heart, Lung, and Blood Institute to support development of Pulmonary Flow Restrictors. "Not only will this new ...See details»
Starlight Cardiovascular Information - RocketReach
Starlightcardio.com; 1 315406XXXX; Ryan Hastings Research And Development Engineer at Starlight Cardiovascular Del Mar, CA, US View. 2 starlightcardio.com; gmail.com; 5 …See details»
Starlight Cardiovascular - Craft
Starlight Cardiovascular has 5 employees at their 1 location and $9.48 m in total funding,. See insights on Starlight Cardiovascular including office locations, competitors, revenue, financials, …See details»
Starlight Cardiovascular Secures $9.48M in Series A Financing to ...
Www.starlightcardio.com. About Investor Bird B AG is a Swiss based, globally active investment company with headquarters in Zug, Switzerland. Founded in 2003 Bird B invests in early …See details»
Starlight Cardiovascular
Starlight Cardiovascular is developing a portfolio of devices for babies born with Congenital Heart Disease.See details»
Starlight Cardiovascular Appoints Paul G. Yock, MD to its Board of ...
Jun 13, 2023 Company developing a cardiovascular medical device portfolio for underserved pediatric population. SAN DIEGO, June 13, 2023 /PRNewswire/ -- Paul G. Yock has joined the …See details»
Starlight Cardiovascular’s Right-Sized Neonatal Stent for …
Jul 5, 2023 Seeing a “blue” baby shortly after giving birth is a new parent’s worst nightmare. Congenital heart defects (CHDs) are the most common group of birth defects, affecting about …See details»
Location — Starlight Cardiovascular
Thank you! We have received your contact request and will respond within a few business days. -Starlight CardiovascularSee details»
Starlight Cardiovascular - PitchBook
Starlight Cardiovascular General Information Description. Developer of a medical device intended to treat babies born with congenital heart disease. The company's devices are regenerative, …See details»
Starlight Cardiovascular: Creating Hope for Little Hearts on …
Mar 20, 2025 Starlight Cardiovascular is featured on Empowered with Meg Ryan, showcasing their commitment to developing medical devices specifically for pediatric heart health.This …See details»
Starlight Cardiovascular - Overview, News & Similar ... - ZoomInfo
Mar 21, 2023 www.starlightcardio.com. Revenue <$5 Million. Industry Medical Devices & Equipment Manufacturing . Recent News & Media. Starlight Cardiovascular Appoints Paul G. …See details»
Starlight Cardiovascular Company Profile -Sales, Contacts, …
Starlight Cardiovascular is in the Surgical and Medical Instruments industry within the Measuring, Photographic, Medical, & Optical Goods, & Clocks sector and has been in business for …See details»
News — Starlight Cardiovascular
Starlight Cardiovascular Awarded $2.16M NIH SBIR Phase II Grant from NHLBI. March 22, 2023See details»
Starlight Cardiovascular: Creating Hope for Little Hearts on …
Mar 20, 2025 Discover the groundbreaking work of Starlight Cardiovascular, a company dedicated to creating life-saving technologies for children with congenital heart disease, a …See details»
Starlight Cardiovascular Secures $9.48M in Series A Financing to ...
SAN DIEGO, Oct. 4, 2022 /PRNewswire/ -- Starlight Cardiovascular announced today that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress …See details»
Starlight Cardiovascular Secures $9.48M in Series A Financing to ...
SAN DIEGO, Oct. 4, 2022 /PRNewswire/ -- Starlight Cardiovascular announced today that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress …See details»
Starlight Cardiovascular Awarded $2.16M NIH SBIR Phase II Grant …
Mar 22, 2023 Award supports design and preclinical testing of pediatric stent. SAN DIEGO, March 22, 2023 /PRNewswire/ -- Starlight Cardiovascular, Inc., a medical device company …See details»